Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures

Sponsor
IRCCS San Raffaele (Other)
Overall Status
Recruiting
CT.gov ID
NCT05141123
Collaborator
(none)
300
19
14
15.8
1.1

Study Details

Study Description

Brief Summary

The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery.

The Registry will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
A Physician-initiated, International, Multi-center, Retrospective and Prospective, Observational Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures
Anticipated Study Start Date :
Oct 30, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Preloaded Fenestrated Stent-graft Designs for Endovascular Aortic Procedures

Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone)

Procedure: Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for
Evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms

Outcome Measures

Primary Outcome Measures

  1. Clinical success [30 days]

    absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

-Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone

Exclusion Criteria:
  • Anatomy requiring sealing in the distal descending thoracic aorta may not be appropriate for a 50 cm sheath due to the risk of it being too short and the graft not reaching the intended landing zone;

  • Celiac trunk or superior mesenteric branch design that makes the graft excessively long;

  • Inability or refusal to give informed consent;

  • Simultaneously participating in another investigative device or drug study;

  • Frank rupture;

  • Systemic infection (eg, sepsis);

  • Allergy to stainless steel, polyester, solder (tin, silver), polypropylene, nitinol, or gold;

  • Untreatable reaction to contrast, which, in the opinion of the investigator, cannot be adequately premedicated.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114
2 UMass Memorial Center for Complex Aortic Disease Worcester Massachusetts United States 01605
3 Southwestern Medical Center, Dallas Dallas Texas United States 75390
4 McGovern Medical School Houston Texas United States 77030
5 University of Washington Seatle Seattle Washington United States 98101
6 Copenhagen Aortic Center Copenhagen Denmark
7 Centre Hospitalier Universitaire Lille France
8 Timone Hospital Marseille Marseille France
9 Centre Hospitalier Universitaire de Nantes Nantes France
10 Aortic Centre Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris Saclay Paris France
11 Hamburg Aortic Center Hamburg Germany
12 Ludwig Maximilian University Hospital Munich Germany
13 St. Franziskus Hospital Münster Germany
14 Policlinico S. Orsola Malpighi Bologna Italy
15 Hospital Doctor Peset Valencia Spain
16 Vascular Center Malmö, Skåne University Hospital Malmö Sweden
17 Department of Surgical Sciences, Vascular Surgery, Uppsala University Uppsala Sweden
18 University Hospitals Birmingham NHS Foundation Trust Birmingham United Kingdom
19 Kings College London United Kingdom

Sponsors and Collaborators

  • IRCCS San Raffaele

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Bertoglio Luca, Prof, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT05141123
Other Study ID Numbers:
  • Preloaded Registry
First Posted:
Dec 2, 2021
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022